Literature DB >> 21592971

Probing the HIV gp120 envelope glycoprotein conformation by NMR.

Jessica Celigoy1, Benjamin Ramirez, Lin Tao, Lijun Rong, Lianying Yan, Yan-Ru Feng, Gerald V Quinnan, Christopher C Broder, Michael Caffrey.   

Abstract

The HIV envelope glycoprotein gp120 plays a critical role in virus entry, and thus, its structure is of extreme interest for the development of novel therapeutics and vaccines. To date, high resolution structural information about gp120 in complex with gp41 has proven intractable. In this study, we characterize the structural properties of gp120 in the presence and absence of gp41 domains by NMR. Using the peptide probe 12p1 (sequence, RINNIPWSEAMM), which was identified previously as an entry inhibitor that binds to gp120, we identify atoms of 12p1 in close contact with gp120 in the monomeric and trimeric states. Interestingly, the binding mode of 12p1 with gp120 is similar for clades B and C. In addition, we show a subtle difference in the binding mode of 12p1 in the presence of gp41 domains, i.e. the trimeric state, which we interpret as small differences in the gp120 structure in the presence of gp41.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21592971      PMCID: PMC3129179          DOI: 10.1074/jbc.M111.251025

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Click chemistry on azidoproline: high-affinity dual antagonist for HIV-1 envelope glycoprotein gp120.

Authors:  Hosahudya N Gopi; Kalyan C Tirupula; Sabine Baxter; Sandya Ajith; Irwin M Chaiken
Journal:  ChemMedChem       Date:  2006-01       Impact factor: 3.466

2.  Three-dimensional solution structure of the 44 kDa ectodomain of SIV gp41.

Authors:  M Caffrey; M Cai; J Kaufman; S J Stahl; P T Wingfield; D G Covell; A M Gronenborn; G M Clore
Journal:  EMBO J       Date:  1998-08-17       Impact factor: 11.598

3.  Atomic structure of the ectodomain from HIV-1 gp41.

Authors:  W Weissenhorn; A Dessen; S C Harrison; J J Skehel; D C Wiley
Journal:  Nature       Date:  1997-05-22       Impact factor: 49.962

4.  Core structure of gp41 from the HIV envelope glycoprotein.

Authors:  D C Chan; D Fass; J M Berger; P S Kim
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

5.  Peptide ligands to human immunodeficiency virus type 1 gp120 identified from phage display libraries.

Authors:  M Ferrer; S C Harrison
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

6.  HIV/SIV glycoproteins: structure-function relationships.

Authors:  N W Douglas; G H Munro; R S Daniels
Journal:  J Mol Biol       Date:  1997-10-17       Impact factor: 5.469

Review 7.  AIDS virus envelope spike structure.

Authors:  Kenneth H Roux; Kenneth A Taylor
Journal:  Curr Opin Struct Biol       Date:  2007-03-28       Impact factor: 6.809

8.  Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody.

Authors:  P D Kwong; R Wyatt; J Robinson; R W Sweet; J Sodroski; W A Hendrickson
Journal:  Nature       Date:  1998-06-18       Impact factor: 49.962

9.  Extensively cross-reactive anti-HIV-1 neutralizing antibodies induced by gp140 immunization.

Authors:  Peng Fei Zhang; Fatim Cham; Ming Dong; Anil Choudhary; Peter Bouma; Zhiqiang Zhang; Yiming Shao; Yan-Ru Feng; Lemin Wang; Nathalie Mathy; Gerald Voss; Christopher C Broder; Gerald V Quinnan
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-31       Impact factor: 11.205

10.  Structure of an unliganded simian immunodeficiency virus gp120 core.

Authors:  Bing Chen; Erik M Vogan; Haiyun Gong; John J Skehel; Don C Wiley; Stephen C Harrison
Journal:  Nature       Date:  2005-02-24       Impact factor: 49.962

View more
  7 in total

1.  A Chemical Probe Strategy for Interrogating Inhibitor Selectivity Across the MEK Kinase Family.

Authors:  Kristine K Deibler; Rama K Mishra; Matthew R Clutter; Aleksandar Antanasijevic; Raymond Bergan; Michael Caffrey; Karl A Scheidt
Journal:  ACS Chem Biol       Date:  2017-03-20       Impact factor: 5.100

2.  Probing the metastable state of influenza hemagglutinin.

Authors:  Carolyn N Kingsley; Aleksandar Antanasijevic; Helena Palka-Hamblin; Matthew Durst; Benjamin Ramirez; Arnon Lavie; Michael Caffrey
Journal:  J Biol Chem       Date:  2017-11-10       Impact factor: 5.157

3.  A model of peptide triazole entry inhibitor binding to HIV-1 gp120 and the mechanism of bridging sheet disruption.

Authors:  Ali Emileh; Ferit Tuzer; Herman Yeh; Muddegowda Umashankara; Diogo R M Moreira; Judith M Lalonde; Carole A Bewley; Cameron F Abrams; Irwin M Chaiken
Journal:  Biochemistry       Date:  2013-03-22       Impact factor: 3.162

4.  New small molecule entry inhibitors targeting hemagglutinin-mediated influenza a virus fusion.

Authors:  Arnab Basu; Aleksandar Antanasijevic; Minxiu Wang; Bing Li; Debra M Mills; Jessica A Ames; Peter J Nash; John D Williams; Norton P Peet; Donald T Moir; Mark N Prichard; Kathy A Keith; Dale L Barnard; Michael Caffrey; Lijun Rong; Terry L Bowlin
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

5.  Comparison of the sensitivities of WaterLOGSY and saturation transfer difference NMR experiments.

Authors:  Aleksandar Antanasijevic; Benjamin Ramirez; Michael Caffrey
Journal:  J Biomol NMR       Date:  2014-09       Impact factor: 2.835

6.  Characterization of influenza hemagglutinin interactions with receptor by NMR.

Authors:  Christopher McCullough; Minxiu Wang; Lijun Rong; Michael Caffrey
Journal:  PLoS One       Date:  2012-07-16       Impact factor: 3.240

Review 7.  Development of Protein- and Peptide-Based HIV Entry Inhibitors Targeting gp120 or gp41.

Authors:  Jing Pu; Qian Wang; Wei Xu; Lu Lu; Shibo Jiang
Journal:  Viruses       Date:  2019-08-01       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.